-transparent.png){kind=logo}
Neocarzinostatin, an antineoplastic agent which is effective against human leukemia, induced unscheduled DNA synthesis in human leukemic leucocytes. This indicated the existence of repair process against at least a part of DNA damage caused by the agent. The extent of unscheduled DNA synthesis increased in parallel with the concentration of Neocarzinostatin up to 5 microgram/ml, followed by a decline at more than 5 microgram/ml. Leucocytes from patients with chronic myelogenous leukemia had higher repair synthesis after Neocarzinostatin treatment compared to those from patients with acute leukemia. The amount of repair synthesis correlated well with the proportion of immature leucocytes among chronic myelogenous leukemia samples, but such correlation was not found among acute leukemia samples.
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
August 1975,
Gan,
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
June 1979,
Biochimica et biophysica acta,
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
January 1983,
Carcinogenesis,
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
May 1988,
Photochemistry and photobiology,
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
November 1985,
Mutation research,
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
November 1982,
Cancer research,
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
May 1980,
Molecular pharmacology,
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
January 1989,
Zeitschrift fur Naturforschung. C, Journal of biosciences,
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
October 1977,
Cancer research,
M Sasada, and
H Sawada, and
T Nakamura, and
H Uchino
December 2004,
Mutation research,
